Skip to content

FERMEDICS: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

FERMEDICS

BE 0698.608.846
NACE 72.101, Research and development on biotechnology
financial year 2025 compared with 2024not consecutivefiled annual accounts (NBB)
Net result for the year
-€60,586
2024 · -€34,834-€25,752
Equity
€14,782
2024 · €75,368-€60,586
Cash
€109,975
2024 · €151,430-€41,455
Balance sheet total
€1.0m
2024 · €983,784+€30,942

Largest movements

2024 to 2025
Assets
  • Stocks and contracts +€238,798

    up €238,798 (+97.8%), from €244,132 to €482,930

  • Deferred charges and accrued income -€104,117

    down €104,117 (-97.0%), from €107,313 to €3,196

  • Receivables within one year -€71,616

    down €71,616 (-26.8%), from €267,293 to €195,677

    of which Trade receivables: -€53,254

  • Cash -€41,455

    down €41,455 (-27.4%), from €151,430 to €109,975

  • Intangible fixed assets +€12,466

    up €12,466 (+5.9%), from €210,043 to €222,508

Equity and liabilities
  • Debts after one year -€147,330

    down €147,330 (-26.8%), from €550,673 to €403,343

  • Other debts +€99,998

    up €99,998 (+52.0%), from €192,163 to €292,161

  • Short-term financial debts +€83,399

    up €83,399 (+120%), from €69,279 to €152,677

  • Profit (loss) carried forward -€60,586

    down €60,586 (-24.9%), from -€243,202 to -€303,788

  • Current portion of long-term debt +€35,389

    up €35,389 (+58.6%), from €60,378 to €95,767

Income statement
  • Gross operating margin +€163,959

    up €163,959 (+405%), from €40,436 to €204,395

  • Depreciation +€84,267

    up €84,267 (+507%), from €16,610 to €100,878

  • Financial charges +€67,949

    up €67,949 (+179%), from €37,858 to €105,808

  • Other operating charges -€28,626

    down €28,626 (-70.1%), from €40,827 to €12,200

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€34,834
Gross operating margin +€163,959
Staff costs -€150
Depreciation -€84,267
Other operating charges +€28,626
Other operating items -€64,427
Financial income -€1,544
Financial charges -€67,949
Result 2025 -€60,586
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

A cash bridge needs two consecutive financial years: one year's result and depreciation cannot explain a change over several years. Pick two years that follow each other.

Every line side by side 42 lines
Line Code 2024 2025 Change %
Total assets 20/58 €983,784 €1,014,726 +€30,942 +3.1%
Fixed assets 21/28 €213,616 €222,949 +€9,333 +4.4%
Intangible fixed assets 21 €210,043 €222,508 +€12,466 +5.9%
Tangible fixed assets 22/27 €3,573 €441 -€3,133 -87.7%
Plant, machinery and equipment 23 €3,573 €441 -€3,133 -87.7%
Current assets 29/58 €770,168 €791,777 +€21,609 +2.8%
Stocks and contracts in progress 3 €244,132 €482,930 +€238,798 +97.8%
Stocks 30/36 €244,132 €482,930 +€238,798 +97.8%
Amounts receivable within one year 40/41 €267,293 €195,677 -€71,616 -26.8%
Trade receivables 40 €232,182 €178,928 -€53,254 -22.9%
Other amounts receivable 41 €35,111 €16,748 -€18,363 -52.3%
Cash at bank and in hand 54/58 €151,430 €109,975 -€41,455 -27.4%
Deferred charges and accrued income 490/1 €107,313 €3,196 -€104,117 -97.0%
Total equity and liabilities 10/49 €983,784 €1,014,726 +€30,942 +3.1%
Equity 10/15 €75,368 €14,782 -€60,586 -80.4%
Contributions 10/11 €318,570 €318,570 = 0.0%
Profit (loss) carried forward 14 -€243,202 -€303,788 -€60,586 -24.9%
Amounts payable 17/49 €908,416 €999,944 +€91,528 +10.1%
Amounts payable after more than one year 17 €550,673 €403,343 -€147,330 -26.8%
Financial debts 170/4 €550,673 €403,343 -€147,330 -26.8%
Amounts payable within one year 42/48 €357,743 €596,601 +€238,858 +66.8%
Current portion of amounts payable after more than one year 42 €60,378 €95,767 +€35,389 +58.6%
Financial debts 43 €69,279 €152,677 +€83,399 +120%
Credit institutions 430/8 €69,279 €152,677 +€83,399 +120%
Trade debts 44 €35,923 €55,995 +€20,073 +55.9%
Suppliers 440/4 €35,923 €55,995 +€20,073 +55.9%
Taxes, remuneration and social security 45 €0 - =
Taxes 450/3 €0 - =
Other amounts payable 47/48 €192,163 €292,161 +€99,998 +52.0%
Remuneration, social security and pensions 62 - €150 +€150
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €16,610 €100,878 +€84,267 +507%
Other operating charges 640/8 €40,827 €12,200 -€28,626 -70.1%
Non-recurring operating charges 66A - €64,427 +€64,427
Gross operating margin 9900 €40,436 €204,395 +€163,959 +405%
Operating profit (loss) 9901 -€17,001 €26,740 +€43,741
Financial income 75/76B €20,025 €18,481 -€1,544 -7.7%
Recurring financial income 75 €20,025 €18,481 -€1,544 -7.7%
Financial charges 65/66B €37,858 €105,808 +€67,949 +179%
Recurring financial charges 65 €37,858 €105,808 +€67,949 +179%
Profit (loss) for the period before taxes 9903 -€34,834 -€60,586 -€25,752 -73.9%
Profit (loss) for the period 9904 -€34,834 -€60,586 -€25,752 -73.9%
Profit (loss) for the period to be appropriated 9905 -€34,834 -€60,586 -€25,752 -73.9%

Source: filed annual accounts (NBB), financial years ended 31 March 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 24 October 2026 via checked.be.